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Supporting Information
Alternative performance metrics
For the purposes of characterization of a particular biocircuit testing environment, in vitro or in vivo,
there are any number of performance metrics that may be used. We have chosen to use integrated mRNA
and final protein concentration since they intuitively represent the total transcriptional and translational
capacity of a system. Other metrics, such as the mRNA and protein production rates and end times, are
complementary to those used in this work and may be particularly informative depending on the specific
circuit or system requirement.
In Figs. S16 and S17 we show the maximum deGFP and MGapt production rates as a function of
reporter concentration under different conditions. Using these measures, stark differences between simple
one-stage gene expression and expression from the two-stage T7 cascade can be seen; for example, at low
reporter concentrations, the maximum production rate of deGFP in the cascade is considerably larger than
the one-stage rate, even when the strongest promoter is used. The cascade deGFP rates are also relatively
flat with respect to reporter concentration. There is also a clear effect of NTPs on peak rates when a
cascade is used versus simple expression. In the former case, additional NTPs provide for a significant
increase in the maximum protein and mRNA production rates, whereas NTPs have little to no effect on
maximum production rates for the Pr-deGFP-MGapt construct.
The deGFP production end time tend,TL is shown for all conditions in Fig. S18. tend,TL is between
330 and 350 minutes for simple expression in the ‘linear’ regime, but as high as ∼580 minutes in some of
the conditions and concentrations tested. The end time is a particularly good measure of system capacity
when extended performance is required.
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Figure S1: Calibration curve relating concentration of purified deGFP-MGapt transcript to initial MGapt
fluorescence signal.
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Figure S2: Decay of purified deGFP-MGapt transcripts in the cell-free breadboard. (A) Degradation is
well-described by single exponential decay with 16–18 min half-lives for a wide range of concentrations.
(B) At high concentrations, the decay curves follow those of the lower concentrations only to 15 min, after
which the half-lives increase dramatically.
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Figure S3: Comparison of total deGFP fluorescence produced by Pr-deGFP and Pr-deGFP-MGapt con-
structs. The incorporation of MGapt in the 3′ UTR downstream of deGFP leads to only a slight increase
in the amount of protein produced relative to deGFP alone, a result we attribute to an increase in the
stability of the fusion transcript conferred by the MGapt.
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Figure S4: Comparison of normalized real-time PCR measurements and MGapt signal for the T7 RNAP
cascade circuit (described in the section titled “Performance of a simple transcription–translation cascade”)
with 1 nM Pr-T7 RNAP and 5 nM PT7-deGFP-MGapt. Shaded region indicates standard error over
replicates.
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Figure S5: MGapt production at early times suggest transcriptional machinery is saturated as DNA
concentration increases. Fits of MGapt production rates in the first 30 minutes of expression follow a
Michaelis-Menten form with Michaelis constant K ∼15 nM.
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Figure S6: (A) MGapt expression curves are well-fit by a single exponential at late times. (B) Decay
constants kdeg determined using a single exponential fit to data after 5 hours of expression. kdeg increases
with increasing DNA concentration.
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Figure S7: (A) The time derivative of the (spline fit) deGFP concentration is proportional to the MGapt
concentration in the first hour of expression. (B) As the experiment goes on and the behavior of the system
is no longer ideal, the shapes of the d
dt
deGFP(t) deviate from MGapt(t) (although there remain significant
qualitative similarities between them; cf. Fig. 1C.
0 0.5 1.0 1.5 2.0
0
2
4
6
8
10
12
14
16
18
0.2 nM
d
e
G
F
P
(t
*)
 (
μ
M
)

 t* MGapt (μM·hr)
0.5 nM
1 nM
2 nM
5 nM
10 nM
20 nM
Pr-deGFP-MGapt
t* = 1, 2, ..., 14 hrs
t* = 6 hrs
t* = 10 hrs
t=0
Figure S8: deGFP at various times t∗ versus MGapt level integrated from time t = 0 to t = t∗ for a
range of Pr-deGFP-MGapt concentrations, with t∗ = 1, 2, . . . , 14 hrs indicated with #. Below the ‘linear’–
‘saturation’ regime transition concentration,
∫ t∗
t=0
MGapt appears proportional to deGFP(t∗) until protein
synthesis stops at t∗ ≈ 340 minutes, albeit with a proportionality constant that is different for different
DNA template concentrations. Above the transition concentration, protein production stops later in the
experiment and the
∫ t∗
t=0
MGapt plateau is relatively short. Dashed lines showing t∗ = 6 hrs and t∗ = 10
hrs are shown for reference.
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Figure S9: Endpoint deGFP versus plasmid concentration for weak promoters Pr1 (left) and Pr2 (right).
Unlike the Pr promoter for which the linear regime ends at 2–5 nM DNA, for Pr1 and Pr2, the linear
regime extends up to ∼10 nM and ∼20 nM, respectively. Dashed line shows a linear fit to the data.
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Figure S10: Comparison of integrated MGapt (left) and endpoint deGFP (right) for promoters Pr, Pr1,
and Pr2.
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Figure S11: MGapt (left) and deGFP (right) expression kinetics when breadboard is supplemented with
1.25 mM of each of the four NTPs. Shaded regions indicate standard error over replicates.
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Figure S12: MGapt expression curves for T7 cascade tested with four different concentrations of first-
stage T7 RNAP plasmid (0.1, 0.2, 0.5, and 1 nM Pr-T7 RNAP) and three different concentrations of the
second-stage plasmid (1, 2, and 10 nM PT7-deGFP-MGapt). Shaded regions indicate standard error over
replicates.
8
0.1 nM Pr-T7RNAP
PT7-deGFP-MGapt 1 nM PT7-deGFP-MGapt 2 nM PT7-deGFP-MGapt 10 nM
0.2 nM Pr-T7RNAP
de
G
FP
 
(μ
M
)
0 100 200 300 400 500 600 700
0.5 nM Pr-T7RNAP
Time (mins)
0 100 200 300 400 500 600 700
1 nM Pr-T7RNAP
0
1
2
3
4
5
6
7
8
9
10
11
0
1
2
3
4
5
6
7
8
9
10
11
Figure S13: deGFP expression curves for T7 cascade tested with four different concentrations of the first-
stage T7 RNAP plasmid (0.1, 0.2, 0.5, and 1 nM Pr-T7 RNAP) and three different concentrations of the
second-stage plasmid (1, 2, and 10 nM PT7-deGFP-MGapt). Shaded regions indicate standard error over
replicates.
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Figure S14: MGapt expression curves for T7 cascade tested with four different concentrations of first-stage
T7 RNAP plasmid (0.1, 0.2, 0.5, and 1 nM Pr-T7 RNAP), three different concentrations of the second-stage
plasmid (1, 2, and 10 nM PT7-deGFP-MGapt), and with the cell-free breadboard supplemented with 1.25
mM of each of the four NTPs. Shaded regions indicate standard error over replicates.
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Figure S15: deGFP expression curves for T7 cascade tested with four different concentrations of the first-
stage T7 RNAP plasmid (0.1, 0.2, 0.5, and 1 nM Pr-T7 RNAP), three different concentrations of the second-
stage plasmid (1, 2, and 10 nM PT7-deGFP-MGapt), and with the cell-free breadboard supplemented with
1.25 mM of each of the four NTPs. Shaded regions indicate standard error over replicates.
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Figure S16: Maximum deGFP production rate as a function of reporter concentration under different
conditions.
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Figure S17: Maximum MGapt production rate as a function of reporter concentration under different
conditions.
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Figure S18: deGFP production end time tend,TL under different conditions.
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Supplementary tables
Table S1: Genotypes of the plasmids used in this study.
TU
Plasmid name Transcription unit (TU) size (bp) Backbone/resistance
pBEST-Pr-GFP PR:deGFP:T500 810 ColE1/Amp
R
pBEST-Pr-∆RBS-GFP PR:∆RBS-deGFP:T500 775 ColE1/Amp
R
pBEST-Pr-GFP-MG PR:deGFP-MGapt:T500 869 ColE1/Amp
R
pBEST-Pr1-GFP-MG PR1:deGFP-MGapt:T500 869 ColE1/Amp
R
pBEST-Pr2-GFP-MG PR2:deGFP-MGapt:T500 869 ColE1/Amp
R
pBEST-Pr-CFP-MG PR:deCFP-MGapt:T500 869 ColE1/Amp
R
pBEST-Pr-T7RNAP PR:T7 RNAP:T500 3032 ColE1/Amp
R
pBEST-Pr1-T7RNAP PR1:T7 RNAP:T500 3032 ColE1/Amp
R
pBEST-Pr2-T7RNAP PR2:T7 RNAP:T500 3032 ColE1/Amp
R
pIVEX-pT7-GFP-MG PT7:deGFP-MGapt:T7term 939 ColE1/Amp
R
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